Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

iwCLL 2025 | Optimizing preventive care for patients with CLL with evidence-based strategies

In this video, Vanthana Bharathi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, emphasizes the importance of hematological oncologists addressing preventive care for patients with chronic lymphocytic leukemia (CLL), highlighting that it may be overlooked by primary care physicians. Dr Bharathi highlights that remaining vigilant when managing this patient population and ensuring timely follow-up on cancer screenings and vaccinations is key. This interview took place at the biennial International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2025 in Krakow, Poland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

I think you know patients with CLL once they get treated they continue to be followed by the CLL physicians or by the primary care physicians. And most of the time the cancer screenings and the vaccinations are taken care of by the primary care physicians but I feel like you know, as in the CLL clinic, especially when we are seeing them in the survivorship clinic, it’s important to kind of address these issues as well, because sometimes we see that it tends to get missed...

I think you know patients with CLL once they get treated they continue to be followed by the CLL physicians or by the primary care physicians. And most of the time the cancer screenings and the vaccinations are taken care of by the primary care physicians but I feel like you know, as in the CLL clinic, especially when we are seeing them in the survivorship clinic, it’s important to kind of address these issues as well, because sometimes we see that it tends to get missed. And it’s good if, you know, there are two people that are looking at these kind of things, making sure that, you know… it just takes two minutes to do these kind of reminders, like asking the patient if they get like their vaccinations like their cancer screenings and making sure that these things are followed through. We do these kind of preventive care and education in our CLL clinic at MD Anderson and it’s worked really well, and so that’s something that I would really recommend. And also, we have really outlined in a table format in our review that we recently published and it’s pretty and it’s a very concise piece of information. It gives you like when you should do the cancer screenings in the real-world in all patients and in patients with CLL, what are the specific things that you need to look at? So yeah, I think being more vigilant in this patient population is important.

 

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...